J1450
J1450 – Injection fluconazole, 200 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 25 NDCs crosswalked per 200 MG $6.105/unit ASP+6%
📋 J1450 summary
J1450 is a HCPCS Level II J-code used to bill fluconazole, 200 mg, billed per 200 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J1450: Fluconazole-Nacl, Fluconazole
Code J1450
Billing unit 200 MG Payment limit $6.105/unit NDC-Crosswalk 25
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ1450
DescriptorInjection fluconazole, 200 mg
Billing unit200 MG
Payment limit / unit$6.105
Est. ASP / unit$5.759 est.
Mapped NDCs25
Data periodQ3 2026
Last updated2026-08-20
💊 About Fluconazole Injection DRUG GUIDE
Fluconazole in Sodium Chloride Injection is used intravenously to treat oropharyngeal candidiasis (a fungal infection of the mouth and throat) and esophageal candidiasis (a fungal infection of the swallowing tube).
It has also been used for Candida urinary tract infections, peritonitis (infection inside the abdominal cavity), and serious systemic Candida infections including candidemia (Candida in the bloodstream), disseminated candidiasis, and Candida pneumonia.Fluconazole in Sodium Chloride Injection is also used to treat cryptococcal meningitis (a fungal infection of the membranes around the brain and spinal cord).
In addition, it is used as a preventive treatment to reduce the risk of candidiasis in patients who receive bone marrow transplants and are undergoing chemotherapy and/or radiation therapy.
Clinical overview from our editorial drug guide for Fluconazole Injection. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$6.105
Est. ASP / unit
$5.759 est.
Est. after 2% sequester
$5.983
HCPCS dosage
200 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection fluconazole, 200 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date2000-01-01
Date added2000-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J1450 = 200 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J1450 WITH EST. MEDICARE PAY
25 NDCs map to J1450. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($6.105/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00338-6045-37 | Fluconazole 400 mg/200mL INJECTION, SOLUTION | Baxter | 10 BAG in 1 CARTON (0338-6045-37) / 200 m... | 400 mg/200mL | 20 | $122.10 | — | ● Active | CMS + PDAC |
| 00338-6046-48 | Fluconazole 200 mg/100mL INJECTION, SOLUTION | Baxter | 10 BAG in 1 CARTON (0338-6046-48) / 100 m... | 200 mg/100mL | 10 | $61.05 | — | ● Active | CMS + PDAC |
| 00409-3435-24 | Fluconazole 200 mg/100mL INJECTION, SOLUTION | Hospira, | 24 POUCH in 1 CARTON (0409-3435-24) / 1 B... | 200 mg/100mL | 24 | $146.52 | — | ● Active | CMS + PDAC |
| 00409-4321-24 | Fluconazole 400 mg/200mL INJECTION, SOLUTION | Hospira, | 24 POUCH in 1 CARTON (0409-4321-24) / 1 B... | 400 mg/200mL | 48 | $293.04 | — | ● Active | CMS + PDAC |
| 00409-4688-12 | Fluconazole In Sodium Chloride | Pfizer | — | — | 48 | $293.04 | — | — | CMS + PDAC |
| 00409-4688-18 | Fluconazole In Sodium Chloride | Pfizer | — | — | 24 | $146.52 | — | — | CMS + PDAC |
| 25021-0184-66 | Fluconazole 2 mg/mL INJECTION, SOLUTION | Sagent | 10 POUCH in 1 CARTON (25021-184-66) / 1 B... | 2 mg/mL | 10 | $61.05 | — | ● Active | CMS + PDAC |
| 25021-0184-67 | Fluconazole 2 mg/mL INJECTION, SOLUTION | Sagent | 10 POUCH in 1 CARTON (25021-184-67) / 1 B... | 2 mg/mL | 20 | $122.10 | — | ● Active | CMS + PDAC |
| 25021-0184-82 | Fluconazole 2 mg/mL INJECTION, SOLUTION | Sagent | 10 POUCH in 1 CARTON (25021-184-82) / 1 B... | 2 mg/mL | 10 | $61.05 | — | ● Active | CMS + PDAC |
| 25021-0184-87 | Fluconazole 2 mg/mL INJECTION, SOLUTION | Sagent | 10 POUCH in 1 CARTON (25021-184-87) / 1 B... | 2 mg/mL | 20 | $122.10 | — | ● Active | CMS + PDAC |
| 70655-0088-10 | FLUCONAZOLE (PF,LATEX-FREE) 400 MG/200 ML | Unknown | — | — | 0.01 | $0.06 | — | — | PDAC |
| 70655-0002-10 | FLUCONAZOLE (PF,LATEX-FREE) 200 MG/100 ML | Unknown | — | — | 0.01 | $0.06 | — | — | PDAC |
| 70655-0002-06 | FLUCONAZOLE (PF,LATEX-FREE) 200 MG/100 ML | Unknown | — | — | 0.01 | $0.06 | — | — | PDAC |
| 63275-9960-01 | FLUCONAZOLE | Unknown | — | — | 5 | $30.53 | — | — | PDAC |
| 63275-9960-02 | FLUCONAZOLE | Unknown | — | — | 5 | $30.53 | — | — | PDAC |
| 63275-9960-04 | FLUCONAZOLE | Unknown | — | — | 5 | $30.53 | — | — | PDAC |
| 63275-9960-05 | FLUCONAZOLE | Unknown | — | — | 5 | $30.53 | — | — | PDAC |
| 63275-9960-09 | FLUCONAZOLE | Unknown | — | — | 5 | $30.53 | — | — | PDAC |
| 51552-1031-02 | FLUCONAZOLE (1X5GM) | Unknown | — | — | 5 | $30.53 | — | — | PDAC |
| 51552-1031-04 | FLUCONAZOLE (1X25GM) | Unknown | — | — | 5 | $30.53 | — | — | PDAC |
| 51552-1031-01 | FLUCONAZOLE (1X1GM) | Unknown | — | — | 5 | $30.53 | — | — | PDAC |
| 69784-0002-06 | FLUCONAZOLE IN SODIUM CHLORIDE (6X100;USP,PF) 200 MG/100 ML | Unknown | — | — | 0.01 | $0.06 | — | — | PDAC |
| 69784-0003-06 | FLUCONAZOLE IN SODIUM CHLORIDE (6X200ML;USP,PF) 400 MG/200 ML | Unknown | — | — | 0.01 | $0.06 | — | — | PDAC |
| 70655-0088-06 | FLUCONAZOLE (PF,LATEX-FREE) 400 MG/200 ML | Unknown | — | — | 0.01 | $0.06 | — | — | PDAC |
| 00409-4688-23 | FLUCONAZOLE (6X100ML,LATEX FREE) 200 MG/100 ML | Unknown | — | — | 0.01 | $0.06 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$308.26
Claims
38
Beneficiaries
—
Spend / beneficiary
—
Spend / claim
$8.11
Trend by period
Where J1450 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #796 of 824
#791
HYDROXYZINE HCL J3410
$391.37
#792
FOLIC ACID J1808
$341.31
#793
METHOTREXATE* J8610
$338.59
#794
PHENYLEPHRINE HCL-0.... J2371
$334.54
#795
CALCIUM GLUCONATE-NA... J0613
$319.51
#796
FLUCONAZOLE-NACL J1450
$308.26
#797
METHADONE HCL J1230
$278.72
#798
LABETALOL HCL J1920
$273.36
#799
CEFUROXIME SODIUM J0697
$269.35
#800
BENTYL* J0500
$265.01
#801
CONRAY Q9961
$251.21
Total claims — #722 of 824
#717
MICAFUNGIN(J2247) J2247
39
#718
PHYTONADIONE* J3430
39
#719
MITOXANTRONE HCL J9293
39
#720
RUCONEST J0596
38
#721
CHLOROTHIAZIDE SODIU... J1205
38
#722
FLUCONAZOLE-NACL J1450
38
#723
VANCOMYCIN HCL(J3374... J3374
38
#724
PERSERIS J2798
37
#725
XYNTHA SOLOFUSE* J7185
37
#726
PEMETREXED(J9314) J9314
37
#727
TYZAVAN* J3375
35
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $308.26 | — | 38 | — | $8.11 |
| 2025 (Q1-Q4) | $477.33 | 32 | 128 | $14.92 | $3.73 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$414.59
Medicare paid
$386.78
Submitted services
1,119
Denial rate
84.5%
Allowed / service
$2.40
Submitted charges
$33.5K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J1450 is utilized
⏳
The geographic utilization map is building for this code — it aggregates millions of CMS Part B claim lines, then caches the result. Refresh in a moment; if it doesn’t appear, this code may have no reportable Part B utilization.
📊 What bills under J1450
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
25 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J1450 billing FAQ
What is HCPCS code J1450?
J1450 is a HCPCS Level II J-code used to bill Injection fluconazole, 200 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J1450?
One unit of J1450 represents 200 MG. Report the number of units equal to the dose administered divided by 200 MG.
How many units of J1450 should I bill?
Divide the dose administered by the code's unit size (200 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J1450?
The Medicare Part B payment limit is $6.105 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $5.983 per unit. Payment limits are revised quarterly.
Which NDCs bill under J1450?
25 NDCs currently map to J1450 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J1450 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.